Keyword: Allergan

News

AbbVie to Sell off Allergan Women’s Health Portfolio

22.03.2021 -

US pharma AbbVie has put compatriot Allergan’s women’s health business up for sale. The company is said to be working with Morgan Stanley on an auction process that has...

News

US FTC Scrutinizes AbbVie/Allergan Deal

04.10.2019 - The US Federal Trade Commission (FTC) has requested additional information from both Allergan and AbbVie as it digs deeper into the proposed merger of the two drugmakers. Biopharma...

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

News

Opioid Makers Angling to Settle out of Court

03.09.2019 - After Johnson & Johnson last week was ordered to pay $572 million to the state of Oklahoma, analysts and other observers said the verdict could prompt other opioid makers to think...

News

AbbVie to Buy Allergan for $63 Billion

27.06.2019 - In a deal expected to close early next year, US biopharma AbbVie is buying troubled Botox manufacturer Allergan for $63 billion in cash and shares. The acquisition is the second...

News

Allergan Boosts Aesthetics with Bonti Buy

20.09.2018 - Drugmaker Allergan is buying Bonti, a privately held, clinical-stage biotech based in Newport Beach, California, USA, that develops novel, fast-acting neurotoxin programs for...

News

Pershing and Valeant Settle Allergan Lawsuits

05.01.2018 - Pershing Square, the hedge fund of US activist investor Bill Ackman, and Canada-based drugmaker Valeant Pharmaceuticals have agreed in principle to pay $290 million to settle two...

News

Teva Confirms Massive Cost Cuts, Job Losses

15.12.2017 - As had been widely expected, Israel-headquartered Teva Pharmaceuticals – world’s largest generics producer – announced on Dec. 14 it would slash 14,000 jobs, about a quarter of its...